AGENDA:

4:00pm: Networking

5:00pm: Welcome remarks

5:05 – 6:15pm: 8 IMPACT startups pitch their solutions

6:15 – 6:45pm: Fireside Chat

6:45 – 7:00pm: 7:00 Networking (+ Prize announcements)

7:00 – 8:00pm: Networking and program close

What is IMPACT?

The M2D2 IMPACT program is a 12-week accelerator program that will run for 7 cycles. The program aims to advance early-stage companies looking to reshape the future of healthcare. Selected companies will have the opportunity to engage with our sponsors’ specialized research calls to help advance their business.

Each IMPACT Cycle closes with an IMPACT Accelerator Pitch-Off. The startups involved in the current cycle will pitch their technology to a panel of experts and innovators on medical device development.

The Cycle 7 Pitch-Off will feature an exciting fireside chat between Oncogenesis CEO Teresa Prego, and Senior Director of Venture Capital at Boston Scientific Craig Smith. They’ll cover key topics like fundraising, reimbursement, pitch deck creation and more!

Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, and Life Sciences Industry Professionals:

Join the Massachusetts life sciences community as the startups from the Cycle 7 Cohort pitch their life sciences solution to a panel of judges. These startups are working with M2D2 to advance the commercialization of their technology through the IMPACT Accelerator Program, sponsored by a group of stakeholders from medtech organizations.